Previous 10 | Next 10 |
PORTLAND, Maine, April 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the h...
ImmuCell (ICCC) reported prelim sales for first quarter ended Mar. 31, 2021."We expect to report a 16%, or $791K, decrease in total product sales to ~$4.1M during the quarter ended Mar. 31, 2021 versus the same period of the prior year, during which our sales benefitted from a higher level of...
PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the h...
ImmuCell Corporation (ICCC) Q4 2020 Earnings Conference Call February 23, 2021 09:00 A.M. ET Company Participants Joe Diaz - Lytham Partners Michael F. Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management George Melas-Kyriazi - MKH Management Unidentifi...
PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve ...
PORTLAND, Maine, Feb. 16, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the he...
ImmuCell ([[ICCC]] +0.5%) expects to report total product sales of ~$15.3M (+12% Y/Y) for the FY20.Company mentions that the First Defense® product line has been exceedingly well received by the market, and has temporarily outstripped their ability to manufacture enough product...
PORTLAND, Maine, Jan. 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
ImmuCell ([[ICCC]] -0.6%) announces restructuring of bank debt, it secured a $1.5M loan from its existing lender, Gorham Savings Bank, with a seven-year term and amortization at 3.5% per annum.Proceeds of ~$624k were used to pay down the outstanding balance on its mortgage loan with Gorham Sa...
PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
News, Short Squeeze, Breakout and More Instantly...
PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the he...
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health an...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...